42 results

• Metformin NDMA Contamination Leads To Teva Pharmaceuticals Recall

  June 10, 2020

  Irvin Jackson

  Teva is recalling 17 lots of generic metformin sold under the Actavis label due to excessive levels of NDMA, a known cancer-causing chemical.

• Metformin Class Action Lawsuit Filed Over Cancer-Causing NDMA Contamination

  March 10, 2020

  Irvin Jackson

  A class action lawsuit claims generic brand of metformin contaminated by NDMA are illegal and seeks reimbursement for all those who purchased the tainted diabetes drug.

• Colon Cancer Lawsuit Filed Over Use Of Recalled Valsartan Products

  February 1, 2019

  Irvin Jackson

  A valsartan recall lawsuit claims that years of using the hypertension drugs led to a case of colon cancer.

• Agreement to Settle Androgel Cases Results in Stay of All Lawsuits Against AbbVie in MDL

  September 11, 2018

  Austin Kirk

  All AndroGel claims have been stayed by a federal judge following an announcement that parties were close to a global settlement agreement.

• Agreement to Settle Testosterone Cases Against Actavis Finalized, Vacating August Trial Date

  July 30, 2018

  Austin Kirk

  The first Androderm bellwether trial has been cancelled after parties involved in Androderm lawsuits finalized a settlement agreement.

• Androderm Settlement Agreement May Resolve 500 Testosterone Lawsuits

  July 5, 2018

  Irvin Jackson

  Parties reached a tentative settlement agreement to resolve all Androderm testosterone lawsuits last month, according to a court order which has paused the litigation to give them time to reach a final agreement.

• Androderm Lawsuits Selected for Potential Bellwether Trials in Testosterone Drug Litigation

  April 13, 2018

  Austin Kirk

  The first group of 100 Androderm lawsuits are being worked up for testosterone bellwether trials set to begin next year.

• Lawsuit Over Pulmonary Embolism from Androgel Ends in Defense Verdict

  January 29, 2018

  Austin Kirk

  Following a defense verdict in an AndroGel lawsuit trial, the settlement of a number of Eli Lilly claims, and another case vacated this week just before trial, the court overseeing all testosterone lawsuits is discussing how to move forward with future bellwether trials.

• New Trial Ordered in Androgel Lawsuit Over Fraudulent Misrepresentation

  December 28, 2017

  Irvin Jackson

  A federal judge has ordered that parts of the first AndroGel bellwether trial be retried, vacating a $150 million punitive damage award and ordering that the new trial focus solely on fraudulent misrepresentation claims.

• Axiron Lawsuits to be Prepared for Bellwether Trials in Early 2018

  August 18, 2016

  Austin Kirk

  Parties have been ordered to select 16 Axiron testosterone heart attack and embolism cases for early trial dates beginning in January 2018.